We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
Impact Health is a mission-driven health policy and strategic consulting firm dedicated to improving health and well-being for all.
OUR SERVICES
Strategic Planning
Integrate mission-aligned policy expertise and political acumen into planning and executing your goals.
Government Contracting
Track record of success supporting states and municipalities in innovating or launching new programs.
Our proprietary method for tracking, aggregating, and analyzing state policy trends.
If you believe that every American deserves to be healthy and well, contact Impact Health Policy Partners to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Impact Health Policy Partners, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Key Takeaways from the PCP and Referring Clinician Webinar for the ACCESS Model
Today, the Center for Medicare & Medicaid Innovation (CMMI/Innovation Center) held a webinar focused on the role of primary care practitioners (PCPs) and referring clinicians in the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model. While the presentation largely reiterated the model’s existing framework, officials provided several new operational clarifications related to care coordination workflows, patient enrollment, and Co-Management Payment… (Testa, June 4, 2026) #Care Coordination, #Delivery Reform, #Demonstration Programs, #Primary Care
Committee Hears Testimony on Dangers and Inconsistencies in Imported Generic Drugs, Hearing on Solutions Will Follow
The Senate Special Committee on Aging convened a hearing to discuss the impact of quality issues in imported generic drugs and active pharmaceutical ingredients (APIs). This hearing focused on describing concerns about the generic drug supply and the Committee plans to hold a subsequent hearing to discuss solutions. Opening Statements: Chair Rick Scott (R-FL) highlighted his concerns about the national security and drug… (McClurg, June 4, 2026) #Biosimilars, #Generic Drugs, #Quality